The Centers for Medicare & Medicaid Services late today announced proposed changes to the Medicare Advantage and Part D prescription drug programs for calendar year 2016, which would reduce payments by a net 0.95%. When combined with expected growth in plan risk scores due to coding, CMS said the changes would increase revenue for MA plans and Part D sponsors by an average 1.05%. Among other policy changes, CMS proposes to reiterate existing rules requiring Medicare Advantage organizations to maintain accurate provider network directories for enrollees; reduce the weight of seven measures in its star rating system to counterbalance the lack of socioeconomic adjustments; and publish information on access to preferred cost sharing pharmacies for each Part D plan offering a preferred cost sharing benefit structure. CMS will accept comments on the 2016 Advance Notice and Draft Call Letter through March 6, and expects to publish a final rate announcement and call letter on April 6.

Related News Articles

Headline
A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the…
Headline
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…
Headline
The Centers for Medicare & Medicaid Services today announced a nationwide initiative aimed at reinforcing eligibility standards for Medicaid and the…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
The AHA will accept applications through Oct. 14 for the 2026 AHA Dick Davidson NOVA Award. This award recognizes hospitals and health systems that demonstrate…
Headline
An article in the latest AHA Trustee Insights newsletter highlights the latest compliance enforcement trends in health care and offers steps for organizations…